A case of premenopausal metastatic breast cancer treated with goserelin plus aromatase inhibitor as second-line endocrine therapy
Baba, S.; Oji, Y.; Teramoto, M.; Kawabata, K.; Saito, A.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(11): 1905-1906
2009
ISSN/ISBN: 0385-0684 PMID: 19920398 Document Number: 634505
A 44-year-old female with premenopausal advanced breast cancer had been treated with a combination of LH-RH analogue and tamoxifen as primary endocrine therapy following adjuvant chemotherapy. Forty-seven months after operation, because metastases of contralateral axillary lymph nodes were detected by computer tomography, she was treated with a combination of LH-RH analogue and aromatase inhibitor as second-line endocrine therapy. During the 16-month administration of LH-RH analogue and aromatase inhibitor, she was been well without new metastatic lesions and maintained a high quality of life.